News
Important Only
Other
BRIEF-Pioneer Power Solutions Inc - Prelim Q4 2024 Revenue From Continuing Operations Up 265% To $9.8 Million
Feb 19 (Reuters) - Pioneer Power Solutions Inc PPSI.O:PIONEER POWER SOLUTIONS INC - PRELIM Q4 2024 REVENUE FROM CONTINUING OPERATIONS UP 265% TO $9.8 MILLIONSource text: ID:nBw7HHY7qaFurther company coverage: PPSI.OReuters
Wed, Feb 19
Commodities
Exxon's gas project in Guyana to include fertilizer plant, executive says
GEORGETOWN, Feb 19 (Reuters) - A large-scale gas project by Exxon Mobil XOM.N in Guyana set to provide natural gas to shore and export liquefied natural gas (LNG) will also include fertilizer plants, the head of the U.S. oil major in Guyana, Alistair Routledge, said on Wednesday.A consortium led by ...Reuters
Wed, Feb 19
Other
BRIEF-Camping World Holdings Inc - Co's Unit Enters Ninth Amended And Restated Credit Agreement
Feb 19 (Reuters) - Camping World Holdings Inc CWH.N:CAMPING WORLD HOLDINGS INC - CO'S UNIT ENTERS NINTH AMENDED AND RESTATED CREDIT AGREEMENTCAMPING WORLD HOLDINGS INC - FLOOR PLAN FACILITY INCREASED TO $2.15 BILLIONCAMPING WORLD HOLDINGS INC - FACILITY AMENDMENT INCLUDES UNCOMMITTED ACCORDION F...Reuters
Wed, Feb 19
Other
BRIEF-Allurion To Raise Approximately $6.1 Million Of Gross Proceeds In Offering And Concurrent Private Placement To Advance Glp-1 Clinical Pipeline
Feb 19 (Reuters) - Allurion Technologies Inc ALUR.N:ALLURION TO RAISE APPROXIMATELY $6.1 MILLION OF GROSS PROCEEDS IN OFFERING AND CONCURRENT PRIVATE PLACEMENT TO ADVANCE GLP-1 CLINICAL PIPELINESource text: ID:nBw9NQX2VaFurther company coverage: ALUR.NReuters
Wed, Feb 19
Other
BRIEF-Primaris REIT Announces Successful $200 Million Unsecured Debenture Offering
Feb 19 (Reuters) - Primaris Real Estate Investment Trust PMZ_u.TO:PRIMARIS REIT ANNOUNCES SUCCESSFUL $200 MILLION UNSECURED DEBENTURE OFFERINGSource text: ID:nBw6KJKzzaFurther company coverage: [PMZ_u.TO]Reuters
Wed, Feb 19
Other
BRIEF-Clarity Receives Us FDA Fast Track Designation For The Treatment Of Metastatic Castration-Resistant Prostate Cancer Patients With Cu-67 Sar-Bispsma
Feb 19 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX:CLARITY RECEIVES US FDA FAST TRACK DESIGNATION FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH CU-67 SAR-BISPSMASource text: ID:nPn29BQ1saFurther company coverage: CU6.AXReuters
Wed, Feb 19
Other
BRIEF-Nisun International Partners With Gold Of China To Expand Gold Business, Targeting $30-$50 Million In Sales Growth From Venture In 2025
Feb 19 (Reuters) - Nisun International Enterprise Development Group Co Ltd NISN.O:NISUN INTERNATIONAL PARTNERS WITH GOLD OF CHINA TO EXPAND GOLD BUSINESS, TARGETING $30-$50 MILLION IN SALES GROWTH FROM VENTURE IN 2025Source text: ID:nPn6fhg61aFurther company coverage: NISN.OReuters
Wed, Feb 19
Other
BRIEF-First Quantum Minerals Announces Cash Tender Offer To Purchase Its Outstanding 6.875% Senior Notes Due 2027 In A Maximum Aggregate Principal Amount Of Up To $500,000,000
Feb 19 (Reuters) - First Quantum Minerals Ltd FM.TO:FIRST QUANTUM MINERALS ANNOUNCES CASH TENDER OFFER TO PURCHASE ITS OUTSTANDING 6.875% SENIOR NOTES DUE 2027 IN A MAXIMUM AGGREGATE PRINCIPAL AMOUNT OF UP TO $500,000,000Source text: ID:nPn4XKNKnaFurther company coverage: FM.TOReuters
Wed, Feb 19
Other
BRIEF-Vertafore Report Shows How Carrier Processes, Communication And Technology Impact The Agent Experience
Feb 19 (Reuters) - Vertafore VTFOR.UL :VERTAFORE REPORT SHOWS HOW CARRIER PROCESSES, COMMUNICATION AND TECHNOLOGY IMPACT THE AGENT EXPERIENCESource text: ID:nPn66hgqlaFurther company coverage: VTFOR.ULReuters
Wed, Feb 19
Other
BRIEF-UK's CMA Says GXO-Wincanton Deal Could Reduce Competition
Feb 19 (Reuters) - UK's CMA:MERGER UPDATE: GXO / WINCANTONGXO'S PURCHASE OF WINCANTON LIKELY TO REDUCE COMPETITION IN SUPPLY OF DEDICATED WAREHOUSING SERVICES TO GROCERY CUSTOMERS IN UKSource text: ID:nRSS7218XaFurther company coverage: GXO.NReuters
Wed, Feb 19
Stocks
BUZZ-Insurer Unum ticks up on $1 billion share repurchase authorization
** Shares of insurer Unum Group UNM.N rise ~1% to $74.72 in early trading** UNM late Tuesday announced its board had authorized repurchase of up to $1 billion of its common stock from time to time beginning on April 1** Co's board also authorize the termination of UNM's current share repurch...Reuters
Wed, Feb 19
Other
Colombia's Grupo Aval forecasts double-digit profitability in 2025
Feb 19 (Reuters) - Colombian financial conglomerate Grupo Aval GAA.CN expects to reach double-digit growth in profitability in 2025, an executive said on Wednesday during a call to present their results. On Tuesday afternoon Aval posted a more than three-fold increase in its net profit in the fourth...Reuters
Wed, Feb 19
Stocks
BUZZ-Workday slips on Morgan Stanley downgrade
** Human resources software provider Workday WDAY.O down 3.5% at $256.31 in morning trading** Morgan Stanley downgrades co to "equal weight" from "overweight", and trims PT to $275 from $330** Brokerage says "recent investments in distribution have failed to catalyze topline grow...Reuters
Wed, Feb 19
Other
BRIEF-Alto Neuroscience Announces U.S. Patent Granted Covering Alto-300 As A Treatment For Patients With Major Depressive Disorder Characterized By An Electroencephalogram Biomarker
Feb 19 (Reuters) - Alto Neuroscience Inc ANRO.N:ALTO NEUROSCIENCE ANNOUNCES U.S. PATENT GRANTED COVERING ALTO-300 AS A TREATMENT FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER CHARACTERIZED BY AN ELECTROENCEPHALOGRAM BIOMARKERSource text: ID:nBw56gCPnaFurther company coverage: ANRO.NReuters
Wed, Feb 19
Other
Herc to buy H&E for $3.83 billion after rival United Rentals exits deal
Feb 19 (Reuters) - Machinery rentals firm Herc Holdings HRI.N has signed a deal to buy H&E Equipment Services HEES.O for $3.83 billion, excluding debt, after H&E terminated its merger agreement with United Rentals URI.N, the companies said on Wednesday.The cash and stock deal will combine th...Reuters
Wed, Feb 19
Other
BRIEF-Alzamend Neuro Announces Completion Of A Novel Head Coil By Tesla For Measuring Brain Structure Lithium Levels In Five Upcoming Phase Ii Clinical Trials At Massachusetts General Hospital
Feb 19 (Reuters) - Alzamend Neuro Inc ALZN.O:ALZAMEND NEURO ANNOUNCES COMPLETION OF A NOVEL HEAD COIL BY TESLA FOR MEASURING BRAIN STRUCTURE LITHIUM LEVELS IN FIVE UPCOMING PHASE II CLINICAL TRIALS AT MASSACHUSETTS GENERAL HOSPITALSource text: ID:nBw3YrfS7aFurther company coverage: ALZN.OReuters
Wed, Feb 19
Other
BRIEF-Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Feb 19 (Reuters) - Twist Bioscience Corp TWST.O:TWIST BIOSCIENCE CORPORATION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw2m9mWZaFurther company coverage: TWST.OReuters
Wed, Feb 19
Other
BRIEF-Ontrak Health And Sentara Health Plans Execute Three-Year Contract Extension Following Several Expansions
Feb 19 (Reuters) - Ontrak Inc OTRK.O:ONTRAK HEALTH AND SENTARA HEALTH PLANS EXECUTE THREE-YEAR CONTRACT EXTENSION FOLLOWING SEVERAL EXPANSIONSONTRAK INC - EXTENDS PARTNERSHIP WITH SENTARA HEALTH PLANS THROUGH DECEMBER 2027Source text: ID:nBw6chb4taFurther company coverage: OTRK.OReuters
Wed, Feb 19
